Glenmark在美国市场上发射价格低廉的通用抗coagulant Phytonadione。 Glenmark launches affordable generic anticoagulant, Phytonadione, in the U.S. market.

Glenmark制药公司在美国推出了一种可注射的通用抗coaguant剂Phytonadione。 Glenmark Pharmaceuticals has launched a generic anticoagulant injectable, Phytonadione, in the US. 10毫克/毫升单剂量安非他明相当于Hospira的Vitamin K1喷射乳胶聚氨酯,目的是在每年销售额约为1 970万美元的市场上提供一个负担得起的替代产品。 The 10 mg/mL single-dose ampules are bioequivalent to Hospira's Vitamin K1 Injectable Emulsion USP, aiming to offer an affordable alternative in a market that generated about $19.7 million in annual sales. 该启动扩大了Glenmark的产品组合,旨在满足未得到满足的医疗需求。 The launch expands Glenmark's product portfolio and aims to meet unmet medical needs.